- |||||||||| Rituxan (rituximab) / Biogen, Zenyaku Kogyo, Roche
Trial completion: MENTOR: MEmbranous Nephropathy Trial Of Rituximab (clinicaltrials.gov) - Apr 30, 2019 P2/3, N=130, Completed, Recruiting --> Completed | Trial completion date: Nov 2018 --> Apr 2019 | Trial primary completion date: Aug 2018 --> Apr 2019 Active, not recruiting --> Completed
- |||||||||| Trial completion: Implantology and Sj (clinicaltrials.gov) - Apr 30, 2019
P=N/A, N=120, Completed, N=86 --> 40 | Recruiting --> Terminated; interim anlaysis failed: palifermin does not promote thymopoeisis after alemtuzumab Recruiting --> Completed
- |||||||||| Trial completion: Rouxbe Pilot for MS (clinicaltrials.gov) - Apr 29, 2019
P=N/A, N=15, Completed, Recruiting --> Completed Recruiting --> Completed
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: REMINDRA: REMission INDuction in Very Early Rheumatoid Arthritis (clinicaltrials.gov) - Apr 29, 2019
P4, N=53, Terminated, Recruiting --> Completed N=267 --> 53 | Trial completion date: Nov 2023 --> Jan 2019 | Recruiting --> Terminated | Trial primary completion date: Nov 2022 --> Jan 2019; low recruitment rate
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date: A Study of Flt3-Ligand Levels in Sjögrens Syndrome (clinicaltrials.gov) - Apr 24, 2019
P=N/A, N=30, Completed, Active, not recruiting --> Completed | N=79 --> 200 Recruiting --> Completed | N=50 --> 30 | Trial completion date: Dec 2019 --> Apr 2019 | Trial primary completion date: Dec 2019 --> Apr 2019
- |||||||||| Keytruda (pembrolizumab) / Merck (MSD), Opdivo (nivolumab) / Ono Pharma, BMS, Yervoy (ipilimumab) / Ono Pharma, BMS
Trial completion, Enrollment change, Checkpoint inhibition, Metastases: CHECKAUTO: Immune Checkpoint Inhibitors and Pre-existing Autoimmune Diseases (clinicaltrials.gov) - Apr 22, 2019 P=N/A, N=112, Completed, Recruiting --> Completed | Trial completion date: Jul 2019 --> Apr 2019 Recruiting --> Completed | N=50 --> 112
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Outcomes Study of the TM Humeral Stem Used in Primary, Total or Hemi Shoulder Arthroplasty (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=67, Terminated, Terminated --> Withdrawn N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study.
- |||||||||| Enrollment change, Trial completion date, Trial termination, Trial primary completion date: Resistance Exercise in Rheumatic Disease (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=15, Terminated, N=120 --> 67 | Trial completion date: Dec 2024 --> Dec 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2023 --> Dec 2018; Business decision was made to remove the CE mark from this product, thus prompting the closing of this study. N=10 --> 15 | Trial completion date: Jun 2019 --> Dec 2018 | Suspended --> Terminated | Trial primary completion date: Jun 2019 --> Dec 2018; Funding ended.
- |||||||||| Hizentra (human immune globulin subcutaneous 20%) / CSL Behring
Phase classification: SIMM: Subcutaneous Ig Maintenance Therapy for Myasthenia Gravis (clinicaltrials.gov) - Apr 20, 2019 P1, N=4, Terminated, N=50 --> 23 | Trial completion date: Dec 2018 --> Jul 2018 | Suspended --> Terminated | Trial primary completion date: Dec 2018 --> Jul 2018; Funding ended Phase classification: P=N/A --> P1
- |||||||||| Biomarker, Trial completion: Salivary Biomarkers for Sj (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=420, Completed, Phase classification: P=N/A --> P1 Active, not recruiting --> Completed
- |||||||||| Enrollment change, Trial termination: Massage Therapy in Juvenile Idiopathic Arthritis (clinicaltrials.gov) - Apr 20, 2019
P=N/A, N=6, Terminated, Active, not recruiting --> Completed N=30 --> 6 | Recruiting --> Terminated; Inability to recruit study participants
- |||||||||| Biomarker, Trial completion date, Trial termination, Trial primary completion date: BioACG: Biomarkers in Giant Cells Arteritis (clinicaltrials.gov) - Apr 18, 2019
P=N/A, N=100, Terminated, Active, not recruiting --> Completed Trial completion date: Oct 2019 --> Jan 2019 | Recruiting --> Terminated | Trial primary completion date: Oct 2019 --> Jan 2019; recruitment failure
- |||||||||| Tysabri (natalizumab) / Biogen, Royalty
Trial completion, Enrollment change, Trial completion date, HEOR, Patient reported outcomes: Does Long-Term Natalizumab (NTZ) Therapy Normalize Brain Atrophy Rates and Quality of Life (QOL) in Relapsing Remitting Multiple Sclerosis (RRMS)? (clinicaltrials.gov) - Apr 17, 2019 P=N/A, N=85, Completed, Trial completion date: Oct 2019 --> Jan 2019 | Recruiting --> Terminated | Trial primary completion date: Oct 2019 --> Jan 2019; recruitment failure Active, not recruiting --> Completed | N=146 --> 85 | Trial completion date: Nov 2019 --> Jan 2019
- |||||||||| Biomarker, Trial completion: A Pilot Study of Biomarkers of Stress in Youth Who Use Teens.Connect (clinicaltrials.gov) - Apr 2, 2019
P=N/A, N=29, Completed, Trial completion date: Dec 2019 --> Feb 2019 | Recruiting --> Terminated | Trial primary completion date: Dec 2019 --> Feb 2019; Lack of trial population, unable to recruit subjects Active, not recruiting --> Completed
- |||||||||| staphylococcal protein A (PRTX-100) / Protalex
Enrollment change, Trial completion date, Trial termination, Trial primary completion date: PRTX-100-203 Open-Label, Dose Escalation Study in Adult Patients With ITP (clinicaltrials.gov) - Mar 25, 2019 P1b, N=15, Terminated, Active, not recruiting --> Completed | Trial completion date: Jun 2019 --> Dec 2018 | Trial primary completion date: Jun 2019 --> Dec 2018 N=30 --> 15 | Trial completion date: Dec 2018 --> May 2018 | Recruiting --> Terminated | Trial primary completion date: Dec 2018 --> May 2018; Enough data has been collected to allow analysis of the safety profile and risk-benefit.
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: Teleconsultation in Type 1 Diabetes Mellitus (clinicaltrials.gov) - Mar 15, 2019
P=N/A, N=150, Completed, Active, not recruiting --> Completed | Trial completion date: Nov 2017 --> Feb 2019 | Trial primary completion date: Oct 2017 --> Feb 2019 Recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Jul 2018
- |||||||||| Trial completion, Enrollment change, Trial completion date, Trial primary completion date, HEOR: LUPP: Pilot Study to Investigate Contemplative Intervention in Lupus Patients (clinicaltrials.gov) - Mar 14, 2019
P=N/A, N=30, Completed, Recruiting --> Completed | Trial completion date: Jul 2017 --> Sep 2018 | Trial primary completion date: Jun 2017 --> Jul 2018 Recruiting --> Completed | N=44 --> 30 | Trial completion date: Feb 2018 --> Jun 2018 | Trial primary completion date: Oct 2017 --> Jun 2018
- |||||||||| Trial completion: Three-dimensional Measurements of Diabetic Foot Ulcers (clinicaltrials.gov) - Mar 13, 2019
P=N/A, N=150, Completed, Recruiting --> Completed | N=44 --> 30 | Trial completion date: Feb 2018 --> Jun 2018 | Trial primary completion date: Oct 2017 --> Jun 2018 Active, not recruiting --> Completed
- |||||||||| Trial completion, Trial completion date, Trial primary completion date: SPIRALE: Study During Pregnancy of Expression of miRNAs in RA or SLE (clinicaltrials.gov) - Mar 7, 2019
P=N/A, N=50, Completed, Active, not recruiting --> Completed Recruiting --> Completed | Trial completion date: Jul 2019 --> Oct 2018 | Trial primary completion date: Jul 2019 --> Oct 2018
|